Femme et Homme
- | Pays :
- Ireland
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to assess whether adding modified-release dipyridamole to aspirin (Asasantin Retard) has measurable effects on markers of platelet function (for example, platelet aggregation) in patients with cardiovascular disease who are known to be resistant to aspirin alone
Critère d'inclusion
- Coronary Arteriosclerosis